Status:
RECRUITING
Heparin for RAO Post-Transradial Angiography in AIS
Lead Sponsor:
Xiang Luo
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Cerebral angiography is a critical diagnostic tool in neurology, serving as the "gold standard" for evaluating cerebrovascular stenosis, hemodynamics, aneurysms, and arteriovenous malformations. Compa...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Acute ischemic stroke onset within 7 days (inclusive)
- Patients undergoing cerebral angiography via transradial approach
- Participant or legal representative capable of providing informed consent
Exclusion
- Current anticoagulation therapy prior to procedure
- Positive modified Allen's test result
- History of coronary artery bypass grafting(CABG) with missing right radial artery graft
- Severe forearm deformities (skin/musculoskeletal) or failed radial artery sheath placement
- Suspected/confirmed pregnancy or lactation
- Acute ischemic stroke with hemorrhagic transformation
- Active systemic bleeding
- Renal insufficiency (eGFR \<30 mL/min or serum creatinine \>200 μmol/L)
- Investigator-determined ineligibility for trial participation
Key Trial Info
Start Date :
August 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT07162064
Start Date
August 4 2025
End Date
May 31 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, China